Pulmonary Fibrosis
Poll on IPF reveals disorder's prevalence far greater than its public awareness
Published in Respiratory Therapeutics Week, September 12th, 2005
According to the poll, awareness of IPF is very low compared to other less prevalent disorders, with less than a third of Americans (29%) knowing anything about the disorder. Forty-four of those familiar with IPF only know its name.
"Public awareness is vital to the fight against IPF," said Mark Shreve, chief executive officer of the CPF. "There is an undeniable correlation between increased public awareness of rare diseases and the amount of resources that are made available to find treatments and cures.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
More Articles from Respiratory Therapeutics Week
- Asthma
Better management of asthma is possible - Chronic Obstructive Pulmonary Disease
Body composition predictive of COPD severity - Complementary & Alternative Medicine
German botanical dietary supplement for respiratory system available in U.S. - Hypertension
Pulmonary arterial smooth muscle cell VEGF expression studied, increase defined - Leukemia
Risk of lung cancer and leukemia from exposure to ionizing radiation studied - Allergy & Immunology
Medical allergy groups urge parents to alert school of their child's condition - More from this issue of Respiratory Therapeutics Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
